ClinicalTrials.Veeva

Menu
V

Vance Thompson Vision | Sioux Falls, SD

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

riboflavin
Prednisolone
K-321
Netarsudil
CBT-001
Ripasudil
Timolol Maleate
Dextenza
QLS-101
Travoprost

Parent organization

This site is a part of Vance Thompson Vision

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 58 total trials

A Cataract Surgery Clinical Trial

The purpose of the study is to compare the efficiency and safety of UNITY™ Vitreoretinal Cataract System (UNITY VCS) to CENTURION® Vision System with...

Begins enrollment in 4 months
Cataract
Device: CENTURION Vision System with Active Sentry
Device: UNITY Vitreoretinal Cataract System

The objective is to evaluate the safety and efficacy of low dose and high dose CBT-001 eye drop dosed twice daily for 24 months compared to vehicle i...

Enrolling
Pterygium
Drug: CBT-001
Drug: Vehicle

The goal of this clinical trial is to learn if MELT-300 works on procedural sedation in adult participants undergoing cataract extraction with lens r...

Enrolling
Cataract
Drug: MELT-300 sublingual tablet
Drug: Placebo sublingual tablet

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

Enrolling
Myopia
Astigmatism
Device: WaveLight Wavefront Optimized
Procedure: Contoura with Phorcides

The objective of this study is to evaluate patient-reported outcomes, surgeon reported outcomes, bruising, symmetry, the success of tissue adhesive f...

Enrolling
Blepharoplasty
Device: Ziplyft

To demonstrate the safety and effectiveness of TearCare® procedures compared to Restasis® to treat the signs and symptoms of dry eye disease in adult...

Active, not recruiting
Dry Eye
Meibomian Gland Dysfunction
Device: TearCare System
Drug: Restasis

Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucom...

Enrolling
Open-Angle Glaucoma
Device: XEN45 (Glaucoma Gel Stent)

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-Related Macular Degeneration

Active, not recruiting
Neovascular Age-Related Macular Degeneration
Drug: OTX-TKI (axitinib implant)
Drug: Aflibercept

Trial sponsors

V
Glaukos logo
A
Johnson & Johnson (J&J) logo
Abbott logo
Alcon logo
AbbVie logo
C
Ocular Therapeutix logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems